- Home
- SIMO vs KNSA Comparison
SIMO vs KNSA Comparison
Compare SIMO & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- KNSA
- Stock Information
- Founded
- SIMO 1995
- KNSA 2015
- Country
- SIMO Hong Kong
- KNSA United Kingdom
- Employees
- SIMO N/A
- KNSA N/A
- Industry
- SIMO Semiconductors
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- SIMO Technology
- KNSA Health Care
- Exchange
- SIMO Nasdaq
- KNSA Nasdaq
- Market Cap
- SIMO 2.4B
- KNSA 1.9B
- IPO Year
- SIMO 2005
- KNSA 2018
- Fundamental
- Price
- SIMO $76.54
- KNSA $30.26
- Analyst Decision
- SIMO Strong Buy
- KNSA Strong Buy
- Analyst Count
- SIMO 8
- KNSA 6
- Target Price
- SIMO $80.00
- KNSA $40.83
- AVG Volume (30 Days)
- SIMO 338.2K
- KNSA 614.0K
- Earning Date
- SIMO 07-30-2025
- KNSA 07-29-2025
- Dividend Yield
- SIMO 2.61%
- KNSA N/A
- EPS Growth
- SIMO N/A
- KNSA N/A
- EPS
- SIMO 2.31
- KNSA 0.07
- Revenue
- SIMO $768,738,000.00
- KNSA $529,332,000.00
- Revenue This Year
- SIMO $2.31
- KNSA $37.21
- Revenue Next Year
- SIMO $13.81
- KNSA $6.10
- P/E Ratio
- SIMO $33.17
- KNSA $459.75
- Revenue Growth
- SIMO N/A
- KNSA 56.18
- 52 Week Low
- SIMO $37.21
- KNSA $17.82
- 52 Week High
- SIMO $85.11
- KNSA $31.92
- Technical
- Relative Strength Index (RSI)
- SIMO 61.37
- KNSA 61.36
- Support Level
- SIMO $75.58
- KNSA $26.27
- Resistance Level
- SIMO $75.21
- KNSA $31.92
- Average True Range (ATR)
- SIMO 3.08
- KNSA 1.03
- MACD
- SIMO 0.07
- KNSA 0.22
- Stochastic Oscillator
- SIMO 43.00
- KNSA 70.62
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.